Cardiovascular Outcomes of Differentiated Thyroid Cancer Patients on Long Term TSH Suppression: A Systematic Review and Meta-Analysis
Hormone and Metabolic Research · 2023-06 · 55 (06) · 379-387
DOI: 10.1055/a-2084-3408 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Hormone and Metabolic Research, online erschienen am 09.06.2023. Verfasst von Jerry Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sydney Medical School, The University of Sydney, Sydney, Australia. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Atrial Fibrillation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
We performed a systematic review and meta-analysis of the literature regarding cardiovascular outcomes of differentiated thyroid cancer (DTC) patients who are on long term thyroid stimulating hormone suppression. Searches were carried out using Prisma guidelines in Medline, Embase, CENTRAL, CINAHL and Scopus databases. Eligible papers were those which investigated discrete cardiovascular clinical outcomes in TSH suppressed patients and meta-analysis of selected studies was performed using Revman 5.4.1. We found a total of 195 879 DTC patients with median length to follow up of 8.6 years (range 5–18.8 years). Analysis showed DTC patients to be at higher risk of atrial fibrillation (HR 1.58, 95% CI 1.40, 1.77), stroke (HR 1.14, 95% CI 1.09, 1.20) and all-cause mortality (HR 2.04, 95% CI 1.02, 4.07). However, there was no difference in risk of heart failure, ischemic heart disease or cardiovascular mortality. These findings suggest that degree of TSH suppression must be titrated to accommodate risk of cancer recurrence and cardiovascular morbidity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Sydney Medical School, The University of Sydney, Sydney, Australia.
- Nepean Institute of Academic Surgery, Nepean Clinical School, The University of Sydney, Sydney, Australia.
- Dept of Surgery, Nepean Hospital, Penrith, Australia.
ORCID-Profile: Femi Emmanuel Ayeni
Zitieren
APA
Yu, J., Kaur, R., Ayeni, F. E., Eslick, G. D., & Edirimanne, S. (2023). Cardiovascular Outcomes of Differentiated Thyroid Cancer Patients on Long Term TSH Suppression: A Systematic Review and Meta-Analysis. Hormone and Metabolic Research, 55(06), 379-387. https://doi.org/10.1055/a-2084-3408
Vancouver
Yu J, Kaur R, Ayeni FE, Eslick GD, Edirimanne S. Cardiovascular Outcomes of Differentiated Thyroid Cancer Patients on Long Term TSH Suppression: A Systematic Review and Meta-Analysis. Hormone and Metabolic Research. 2023;55(06):379-387. doi:10.1055/a-2084-3408
BibTeX
@article{Yu2023,
author = {Yu, Jerry and Kaur, Rajneesh and Ayeni, Femi Emmanuel and Eslick, Guy D and Edirimanne, Senarath},
title = {Cardiovascular Outcomes of Differentiated Thyroid Cancer Patients on Long Term TSH Suppression: A Systematic Review and Meta-Analysis},
journal = {Hormone and Metabolic Research},
year = {2023},
volume = {55},
number = {06},
pages = {379--387},
doi = {10.1055/a-2084-3408}
}
EUVIMED